Bernardo L Rapoport: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

ONS Guidelinesâ¢ for Cancer TreatmentâRelated Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer

Kaplan, Marcelle, Ginex, Pamela, Michaud, Laura, FernÃ¡ndez-Ortega, Paz, Grimmer, Dale, Leibelt, Jessica, Mahon, Suzanne, Rapoport, Bernardo, Robinson, Valencia, Maloney, Christine, Moriarty, Kerri, V

Journal:

Oncology Nursing Forum

Year:

2020

File:

PDF, 212 KB

2020

2

Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors

Yevgeniy Balagula, Claus Garbe, Patricia L. Myskowski, Axel Hauschild, Bernardo L. Rapoport, Christine B. Boers-Doets, Mario E. Lacouture

Journal:

International Journal of Dermatology

Year:

2011

Language:

english

File:

PDF, 472 KB

english, 2011

3

The MASCC Neutropenia, Infection and Myelosuppression Study Group evaluates recent new concepts for the use of granulocyte colony-stimulating factors for the prevention of febrile neutropenia

Klastersky, Jean, Raftopoulos, Harry, Rapoport, Bernardo

Journal:

Supportive Care in Cancer

Year:

2013

Language:

english

File:

PDF, 95 KB

english, 2013

4

Efficacy of a triple antiemetic regimen with aprepitant for the prevention of chemotherapy-induced nausea and vomiting: effects of gender, age, and region

Rapoport, Bernardo L.

Journal:

Current Medical Research and Opinion

Year:

2014

Language:

english

File:

PDF, 229 KB

english, 2014

5

Supportive care for patients undergoing immunotherapy

Rapoport, Bernardo Leon, van Eeden, Ronwyn, Sibaud, Vincent, Epstein, Joel B., Klastersky, Jean, Aapro, Matti, Moodley, Devan

Journal:

Supportive Care in Cancer

Year:

2017

Language:

english

File:

PDF, 511 KB

english, 2017

6

Fast Facts: Manejo de eventos adversos relacionados con el sistema inmunitario en oncologÃa || Eventos adversos relacionados con el sistema endocrino

Rapoport, Bernardo L., Westman, Helen

Year:

2020

File:

PDF, 1.09 MB

2020

7

Cyclophosphamide, etoposide, vincristine, adriamycin, and dexamethasone (CEVAD) regimen in refractory multiple myeloma: An international oncology study group (IOSG) phase II protocol

Giles, Francis J., Wickham, Nicholas R., Rapoport, Bernardo L., Somlo, George, Lim, Stephen W., Shan, Jianqin, Lynott, Anne M.

Journal:

American Journal of Hematology

Year:

2000

Language:

english

File:

PDF, 43 KB

english, 2000

8

Repeated use of granisetron in patients receiving cytostatic agents

Magriet De Wet, Geoffrey Falkson, Bernardo L. Rapoport

Journal:

Year:

1993

Language:

english

File:

PDF, 649 KB

english, 1993

9

Doxorubicin-paclitaxel : A safe regimen in terms of cardiac toxicity in metastatic breast carcinoma patients. Results from a European Organization for Research and Treatment of Cancer multicenter trial

Laura Biganzoli, Tanja Cufer, Peter Bruning, Robert E. Coleman, Luc Duchateau, Bernardo Rapoport, Marianne Nooij, François Delhaye, D. Miles, Aaron Sulkes, A. Hamilton, Martine Piccart

Journal:

Year:

2003

Language:

english

File:

PDF, 93 KB

english, 2003

10

Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy

Timothy J. Littlewood, Johan Nortier, Bernardo Rapoport, Marek Pawlicki, Gilbert De Wasch, Els Vercammen, Wolfgang Schuette, Jacques Wils, Mathias Freund

Journal:

Hematological Oncology

Year:

2003

Language:

english

File:

PDF, 128 KB

english, 2003

11

Phase II clinical study of pirarubicin in hormone resistant prostate cancer

Bernardo Leon Rapoport, Geoffrey Falkson

Journal:

Investigational New Drugs

Year:

1992

Language:

english

File:

PDF, 178 KB

english, 1992

12

Febrile neutropenia: a prospective study to validate the Multinational Association of Supportive Care of Cancer (MASCC) risk-index score

Almarie Uys, Bernardo L. Rapoport, Ronald Anderson

Journal:

Supportive Care in Cancer

Year:

2004

Language:

english

File:

PDF, 129 KB

english, 2004

13

Antiemetic therapy for multiple-day chemotherapy and high-dose chemotherapy with stem cell transplant: review and consensus statement

Lawrence H. Einhorn, Bernardo Rapoport, Jim Koeller, Steven M. Grunberg, Petra Feyer, Cynthia Rittenberg, Matti Aapro

Journal:

Supportive Care in Cancer

Year:

2005

Language:

english

File:

PDF, 108 KB

english, 2005

14

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—an update

Steven M. Grunberg, David Osoba, Paul J. Hesketh, Richard J. Gralla, Sussanne Borjeson, Bernardo L. Rapoport, Andreas du Bois, Maurizio Tonato

Journal:

Supportive Care in Cancer

Year:

2005

Language:

english

File:

PDF, 71 KB

english, 2005

15

Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind study

Bernardo L. Rapoport, Karin Jordan, Judith A. Boice, Arlene Taylor, Carole Brown, James S. Hardwick, Alexandra Carides, Timothy Webb, Hans-Joachim Schmoll

Journal:

Supportive Care in Cancer

Year:

2010

Language:

english

File:

PDF, 174 KB

english, 2010

16

Antiemetic therapy for multiple-day chemotherapy and additional topics consisting of rescue antiemetics and high-dose chemotherapy with stem cell transplant: review and consensus statement

Lawrence H. Einhorn, Steven M. Grunberg, Bernardo Rapoport, Cynthia Rittenberg, Petra Feyer

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 90 KB

english, 2011

17

Acute emesis: moderately emetogenic chemotherapy

Jørn Herrstedt, Bernardo Rapoport, David Warr, Fausto Roila, Emilio Bria, Cynthia Rittenberg, Paul J. Hesketh

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 151 KB

english, 2011

18

Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?

Marianne Paesmans, Jean Klastersky, Johan Maertens, Aspasia Georgala, Frédérique Muanza, Mickael Aoun, Augustin Ferrant, Bernardo Rapoport, Ken Rolston, Lieveke Ameye

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 193 KB

english, 2011

19

Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity—state of the art

Steven M. Grunberg, David Warr, Richard J. Gralla, Bernardo L. Rapoport, Paul J. Hesketh, Karin Jordan, Birgitte T. Espersen

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 95 KB

english, 2011

20

Incidence of delayed nausea and vomiting in patients with colorectal cancer receiving irinotecan-based chemotherapy

Paul J. Hesketh, Snezana M. Bosnjak, Vlada Nikolic, Bernardo Rapoport

Journal:

Supportive Care in Cancer

Year:

2011

Language:

english

File:

PDF, 158 KB

english, 2011

21

Management of the Cancer Patient With Infection and Neutropenia

Bernardo Leon Rapoport

Journal:

Seminars in Oncology

Year:

2011

Language:

english

File:

PDF, 203 KB

english, 2011

22

Phase I/II study of first-line irinotecan combined with 5-fluorouracil and folinic acid Mayo Clinic schedule in patients with advanced colorectal cancer

Thomas Kuehr, Paul Ruff, Bernardo L Rapoport, Stephen Falk, Francis Daniel, Conrad Jacobs, Neville Davidson, Josef Thaler, Blandine Boussard, James Carmichael

Journal:

Year:

2004

Language:

english

File:

PDF, 304 KB

english, 2004

23

Comparison of an orally disintegrating ondansetron tablet with the conventional ondansetron tablet for cyclophosphamide-induced emesis in cancer patients: A multicenter, double-masked study

Neville Davidson, Bernardo Rapoport, Bjorn Erikstein, Bernard L'Esperance, Paul Ruff, Walter Paska, Irene Miller, Paula Curtis

Journal:

Clinical Therapeutics

Year:

1999

Language:

english

File:

PDF, 741 KB

english, 1999

24

O-52 ECOG 1599: Randomized phase II study of paclitaxel/carboplatin vs cisplatin/gemcitabine in performance status (PS) 2 patients with treatment-naive advanced NSCLC

Langer, Corey J., Stephenson, Patricia, Schiller, Joan, Tester, William J., Rapoport, Bernardo L., Johnson, David

Journal:

Year:

2003

Language:

english

File:

PDF, 184 KB

english, 2003

25

O-250 Are lung cancer patients (pts) with febrile neutropenia (FN) different from other solid tumor pts? An analysis according to the MASCC score predicting risk of serious medical complication

Paesmans, Marianne, Barette, Martine, Rapoport, Bernardo, Slabber, Coenraad, Plehiers, Barbara, Alexopoulos, Costas, Dubreucq, Laurent, Georgala, Aspasia, Muanza, FrédéRique, Klastersky, Jean

Journal:

Year:

2003

Language:

english

File:

PDF, 182 KB

english, 2003

26

Trisomy 5 in Ph+ chronic myeloid leukemia in association with megakaryocytosis

Stephen M. Ansell, Bernardo L. Rapoport, Maria A. Coccia-Portugal, Kenneth Stevens, Catharina J. Bester, Geoffrey Falkson

Journal:

Cancer Genetics and Cytogenetics

Year:

1991

Language:

english

File:

PDF, 123 KB

english, 1991

27

Completeness in the Reporting of Dermatologic Adverse Drug Reactions Associated with Monoclonal Antibody Epidermal Growth Factor Receptor Inhibitors in Phase II and III Colorectal Cancer Clinical Trials

Kimberly A. Bauer, Scott Hammerman, Bernardo Rapoport, Mario E. Lacouture

Journal:

Clinical Colorectal Cancer

Year:

2008

Language:

english

File:

PDF, 107 KB

english, 2008

28

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial

José Baselga, Frederico Costa, Henry Gomez, Clifford A Hudis, Bernardo Rapoport…

Journal:

Year:

2013

Language:

english

File:

PDF, 246 KB

english, 2013

29

When and How Do I Use Neoadjuvant Chemotherapy for Breast Cancer?

Rapoport, Bernardo L., Demetriou, Georgia S., Moodley, Shun D., Benn, Carol A.

Journal:

Current Treatment Options in Oncology

Year:

2014

Language:

english

File:

PDF, 154 KB

english, 2014

30

A phase II clinical study of suramin in combination with mitomycin C in patients with non small cell lung cancer

Rapoport, Bernardo Leon, Falkson, Geoffrey, Ansell, Stephen Maxted, Lotz, Barend Petrus, de Wet, Magriet

Journal:

Year:

1991

Language:

english

File:

PDF, 409 KB

english, 1991

31

Study of rolapitant, a novel, long-acting, NK-1 receptor antagonist, for the prevention of chemotherapy-induced nausea and vomiting (CINV) due to highly emetogenic chemotherapy (HEC)

Rapoport, Bernardo, Chua, Daniel, Poma, Allen, Arora, Sujata, Wang, Yan, Fein, Luis Enrique

Journal:

Supportive Care in Cancer

Year:

2015

Language:

english

File:

PDF, 320 KB

english, 2015

32

Malaria Parasitemia Associated with Febrile Neutropenia in African Patients Undergoing Chemotherapy for Haematological Malignancies

Rapoport, Bernardo L., Uys, Almarie

Journal:

Year:

2008

Language:

english

File:

PDF, 92 KB

english, 2008

33

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials

Rapoport, Bernardo L, Chasen, Martin R, Gridelli, Cesare, Urban, Laszlo, Modiano, Manuel R, Schnadig, Ian D, Poma, Allen, Arora, Sujata, Kansra, Vikram, Schwartzberg, Lee S, Navari, Rudolph M

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 373 KB

english, 2015

34

Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial

Schwartzberg, Lee S, Modiano, Manuel R, Rapoport, Bernardo L, Chasen, Martin R, Gridelli, Cesare, Urban, Laszlo, Poma, Allen, Arora, Sujata, Navari, Rudolph M, Schnadig, Ian D

Journal:

The Lancet Oncology

Year:

2015

Language:

english

File:

PDF, 250 KB

english, 2015

35

Sorafenib: a brief review with emphasis on its possible role in breast cancer

Rapoport, Bernardo L

Journal:

Breast Cancer Management

Year:

2015

Language:

english

File:

PDF, 1.46 MB

english, 2015

36

Rolapitant for the treatment of chemotherapy-induced nausea and vomiting: a review of the clinical evidence

Chasen, Martin R, Rapoport, Bernardo L

Journal:

Future Oncology

Year:

2016

Language:

english

File:

PDF, 2.03 MB

english, 2016

37

Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy

Rapoport, Bernardo, Schwartzberg, Lee, Chasen, Martin, Powers, Dan, Arora, Sujata, Navari, Rudolph, Schnadig, Ian

Journal:

European Journal of Cancer

Year:

2016

Language:

english

File:

PDF, 468 KB

english, 2016

38

The emerging problem of bacterial resistance in cancer patients; proceedings of a workshop held by MASCC “Neutropenia, Infection and Myelosuppression” Study Group during the MASCC annual meeting held in Berlin on 27–29 June 2013

Rapoport, Bernardo, Klastersky, Jean, Raftopoulos, Harry, Freifeld, Allison, Aoun, Mickael, Zinner, Stephen H., Rolston, Kenneth V.I.

Journal:

Supportive Care in Cancer

Year:

2016

Language:

english

File:

PDF, 316 KB

english, 2016

39

Phase II study of pegylated liposomal doxorubicin in patients with metastatic malignant melanoma failing standard chemotherapy treatment

Vorobiof, Daniel A, Rapoport, Bernardo L, Mahomed, Rabia, Karime, Margaret

Journal:

Melanoma Research

Year:

2003

Language:

english

File:

PDF, 65 KB

english, 2003

40

Triple-negative breast cancer – the past, present and future: recent and emerging trends in immunotherapy

Eeden, Ronwyn van, Rapoport, Bernardo L

Journal:

Breast Cancer Management

Year:

2016

Language:

english

File:

PDF, 1.83 MB

english, 2016

41

Current trends in the management of anaemia in solid tumours and haematological malignancies

van Eeden, Ronwyn, Rapoport, Bernardo L.

Journal:

Current Opinion in Supportive and Palliative Care

Year:

2016

Language:

english

File:

PDF, 209 KB

english, 2016

42

2016 Updated MASCC/ESMO consensus recommendations: Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents

Jordan, Karin, Chan, Alexandre, Gralla, Richard J., Jahn, Franziska, Rapoport, Bernardo, Warr, David, Hesketh, Paul J.

Journal:

Supportive Care in Cancer

Year:

2017

Language:

english

File:

PDF, 359 KB

english, 2017

43

2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy

Roila, Fausto, Warr, David, Hesketh, Paul J., Gralla, Richard, Herrstedt, Jorn, Jordan, Karin, Aapro, Matti, Ballatori, Enzo, Rapoport, Bernardo

Journal:

Supportive Care in Cancer

Year:

2017

Language:

english

File:

PDF, 321 KB

english, 2017

44

2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential

Olver, Ian, Ruhlmann, Christina H., Jahn, Franziska, Schwartzberg, Lee, Rapoport, Bernardo, Rittenberg, Cynthia N., Clark-Snow, Rebecca

Journal:

Supportive Care in Cancer

Year:

2017

Language:

english

File:

PDF, 274 KB

english, 2017

45

A raridade histológica no câncer da tireoide

Vianna, Débora Modelli, Curioni, Otávio Alberto, França, Luciano José de Lemos, Paiva, Diógenes Lopes de, Pompeu, Bernardo Fontel, Dedivitis, Rogério Aparecido, Rapoport, Abrão

Journal:

Brazilian Journal of Otorhinolaryngology

Year:

2012

Language:

english

File:

PDF, 1.60 MB

english, 2012

46

Erratum to: 2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapy

Roila, Fausto, Warr, David, Hesketh, Paul J., Gralla, Richard, Herrstedt, Jorn, Jordan, Karin, Aapro, Matti, Ballatori, Enzo, Rapoport, Bernardo

Journal:

Supportive Care in Cancer

Year:

2017

Language:

english

File:

PDF, 213 KB

english, 2017

47

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy

Chasen, Martin, Urban, Laszlo, Schnadig, Ian, Rapoport, Bernardo, Powers, Dan, Arora, Sujata, Navari, Rudolph, Schwartzberg, Lee, Gridelli, Cesare

Journal:

Supportive Care in Cancer

Year:

2017

Language:

english

File:

PDF, 459 KB

english, 2017

48

2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting

Einhorn, Lawrence H., Rapoport, Bernardo, Navari, Rudolph M., Herrstedt, Jørn, Brames, Mary J.

Journal:

Supportive Care in Cancer

Year:

2017

Language:

english

File:

PDF, 284 KB

english, 2017

49

Rolapitant for the prevention of delayed nausea and vomiting over initial and repeat courses of emetogenic chemotherapy

Rapoport, Bernardo, van Eeden, Ronwyn, Smit, Teresa

Journal:

Expert Review of Clinical Pharmacology

Year:

2017

Language:

english

File:

PDF, 1.27 MB

english, 2017

50

Clinical pharmacology of neurokinin-1 receptor antagonists for the treatment of nausea and vomiting associated with chemotherapy

Rapoport, Bernardo, Smit, Teresa

Journal:

Expert Opinion on Drug Safety

Year:

2017

Language:

english

File:

PDF, 865 KB

english, 2017